Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Jul 18;144(3):247-248.
doi: 10.1182/blood.2024025031.

Gasdermin D and TMA

Lijun Xia  1
Affiliations
Editorial

Gasdermin D and TMA

Lijun Xia. Blood. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: L.X. declares no competing financial interests.

Figures

None
Model depicting cholesterol emboli, originating from the atheromatous plaques of the abdominal aorta, activate gasdermin D on neutrophils, leading to pyroptosis-mediated neutrophil extracellular trap (NET)osis, thromboinflammation, and subsequent obstruction of microcirculation in the kidney. Figure created using bioRender.
See this image and copyright information in PMC

Comment on

References

    1. Watanabe-Kusunoki K, Li C, Bandeira Honda TS, et al. Gasdermin D drives focal crystalline thrombotic microangiopathy by accelerating immunothrombosis and necroinflammation. Blood. 2024;144(3):308–322. - PubMed
    1. George JN, Nester CM. Syndromes of thrombotic microangiopathy. N Engl J Med. 2014;371(7):654–666. - PubMed
    1. Devant P, Kagan JC. Molecular mechanisms of gasdermin D pore-forming activity. Nat Immunol. 2023;24(7):1064–1075. - PubMed
    1. Kronzon I, Saric M. Cholesterol embolization syndrome. Circulation. 2010;122(6):631–641. - PubMed
    1. Brocklebank V, Wood KM, Kavanagh D. Thrombotic microangiopathy and the kidney. Clin J Am Soc Nephrol. 2018;13(2):300–317. - PMC - PubMed